ZA200301047B - New macrolides with antibacterial activity. - Google Patents

New macrolides with antibacterial activity. Download PDF

Info

Publication number
ZA200301047B
ZA200301047B ZA200301047A ZA200301047A ZA200301047B ZA 200301047 B ZA200301047 B ZA 200301047B ZA 200301047 A ZA200301047 A ZA 200301047A ZA 200301047 A ZA200301047 A ZA 200301047A ZA 200301047 B ZA200301047 B ZA 200301047B
Authority
ZA
South Africa
Prior art keywords
compound
thio
compounds
formula
treatment
Prior art date
Application number
ZA200301047A
Other languages
English (en)
Inventor
Peter Angehrn
Pierre-Charles Wyss
Daniel Hunziker
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of ZA200301047B publication Critical patent/ZA200301047B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA200301047A 2000-08-22 2003-02-06 New macrolides with antibacterial activity. ZA200301047B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00117971 2000-08-22

Publications (1)

Publication Number Publication Date
ZA200301047B true ZA200301047B (en) 2004-05-06

Family

ID=8169600

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200301047A ZA200301047B (en) 2000-08-22 2003-02-06 New macrolides with antibacterial activity.

Country Status (14)

Country Link
US (1) US6740642B2 (enExample)
EP (1) EP1313751B1 (enExample)
JP (1) JP4162992B2 (enExample)
KR (1) KR100502031B1 (enExample)
CN (1) CN1234718C (enExample)
AT (1) ATE408614T1 (enExample)
AU (1) AU2001282105A1 (enExample)
BR (1) BR0113472A (enExample)
CA (1) CA2419296C (enExample)
DE (1) DE60135859D1 (enExample)
ES (1) ES2313975T3 (enExample)
MX (1) MXPA03001607A (enExample)
WO (1) WO2002016380A1 (enExample)
ZA (1) ZA200301047B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275621T3 (es) * 2000-12-21 2007-06-16 Glaxo Group Limited Antibioticos macrolidos.
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
CN1589277A (zh) * 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6-o-氨基甲酸酯-11,12-内酯-酮内酯抗菌剂
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US6727229B2 (en) * 2002-08-19 2004-04-27 Enanta Pharmaceuticals, Inc. 11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en) 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
US6716820B1 (en) 2003-06-05 2004-04-06 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic macrolides
US20040254126A1 (en) * 2003-06-05 2004-12-16 Yao-Ling Qiu 11-12 Bicyclic erythromycin derivatives
US6790835B1 (en) 2003-06-05 2004-09-14 Enanta Pharmaceuticals, Inc. Bicyclic macrolide derivatives
US6774115B1 (en) 2003-06-05 2004-08-10 Enanta Pharmaceuticals, Inc. 6-O-substituted bicyclic ketolides
WO2004108745A2 (en) * 2003-06-05 2004-12-16 Enanta Pharmaceuticals, Inc. 11-12 bicyclic erythromycin derivatives
US6765016B1 (en) 2003-06-05 2004-07-20 Enanta Pharmaceuticals, Inc. Bicyclic ketolide derivatives
WO2006065721A2 (en) * 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
DE602006006030D1 (de) * 2005-02-09 2009-05-14 Basilea Pharmaceutica Ag Neue makrolide
CN101115764B (zh) * 2005-02-09 2012-09-26 巴斯利尔药物股份公司 大环内酯类化合物
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
JP2009506066A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ,インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
PT2049556E (pt) * 2006-08-09 2013-08-22 Basilea Pharmaceutica Ag Novos macrólidos úteis contra doenças inflamatórias e alérgicas
EP2056844A4 (en) * 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
CN101939327B (zh) * 2008-02-08 2015-03-11 巴斯利尔药物股份公司 新的大环内酯类及其用途
JP5769972B2 (ja) * 2008-02-08 2015-08-26 バジリア ファルマスーチカ アーゲーBasilea Pharmaceutica AG Pde阻害により仲介される疾患を処置するためのマクロライド
RU2011153353A (ru) * 2009-05-27 2013-07-10 Вокхардт Рисерч Сентер Кетолидные соединения, обладающие противомикробной активностью
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
CN102417530A (zh) * 2010-09-26 2012-04-18 中国医学科学院药物研究所 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
EP3216798A3 (en) 2010-12-09 2017-10-25 Wockhardt Limited Ketolide compounds
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates
PL2938623T3 (pl) * 2012-12-31 2017-03-31 Basilea Pharmaceutica Ag Wybrane makrolidy o działaniu hamującym pde4
US10857171B2 (en) 2016-01-12 2020-12-08 Wockhardt Limited Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
DE60135859D1 (de) 2008-10-30
AU2001282105A1 (en) 2002-03-04
MXPA03001607A (es) 2003-06-04
EP1313751A1 (en) 2003-05-28
CN1234718C (zh) 2006-01-04
CA2419296C (en) 2008-12-09
ES2313975T3 (es) 2009-03-16
JP2004506740A (ja) 2004-03-04
ATE408614T1 (de) 2008-10-15
CA2419296A1 (en) 2002-02-28
KR20030029839A (ko) 2003-04-16
KR100502031B1 (ko) 2005-07-25
WO2002016380A1 (en) 2002-02-28
US20030199459A1 (en) 2003-10-23
JP4162992B2 (ja) 2008-10-08
BR0113472A (pt) 2003-07-01
US6740642B2 (en) 2004-05-25
EP1313751B1 (en) 2008-09-17
CN1464880A (zh) 2003-12-31

Similar Documents

Publication Publication Date Title
US6740642B2 (en) Macrolides with antibacterial activity
KR101566053B1 (ko) 항균 활성을 갖는 케톨라이드
EP2464651B1 (en) New macrolides and their use
BG65107B1 (bg) 13-членни азалиди и тяхното използване като антибиотични средства
CA2301643A1 (en) 6,9-bridged erythromycin derivatives
EP1478653A1 (en) Macrolides with antibacterial activity
EP1628989B1 (en) Novel 14 and 15 membered-ring compounds
KR101617897B1 (ko) 신규 마크로라이드 및 그의 용도
PL191087B1 (pl) 3,6-hemiketale oraz sposób ich wytwarzania
KR20070085919A (ko) 마크로론 - 아미노 치환된 퀴놀론
JP2008519787A (ja) マクロロン化合物
EP0262904A2 (en) Modifications of mycinose and 3-0-demethylmycinose in tylosintype macrolides
EP1846430B1 (en) New macrolides
EP1328535B1 (en) Macrolides
JP2006528947A (ja) 4”−置換マクロライド
JP2001518475A (ja) 環状亜リン酸およびリン酸塩
EP1756134A1 (en) Carbamate linked macrolides useful for the treatment of microbial infections
JP2008519789A (ja) マクロロン化合物